Armistice Capital, LLC Johnson & Johnson Transaction History

Armistice Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $50.7 Million - $56.8 Million	-325,622 Reduced 70.79%	134,378 $20.9 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $326,758 - $351,654	2,117 Added 0.46%	460,000 $76.1 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $60.1 Million - $71.7 Million	397,883 Added 663.14%	457,883 $71 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $3.2 Million - $3.6 Million	-20,000 Reduced 25.0%	60,000 $10.6 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $28.4 Million - $31.6 Million	-176,000 Reduced 68.75%	80,000 $13.1 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $43.1 Million - $47.6 Million	256,000 New	256,000 $45.4 Million

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $379B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.